Different patterns of alcohol consumption and the incidence and persistence of depressive and anxiety symptoms among older adults in Ireland: A prospective community-based study.
Por:
Carvalho AF, Stubbs B, Maes M, Solmi M, Vancampfort D, Kurdyak PA, Brunoni AR, Husain MI and Koyanagi A
Publicada:
1 oct 2018
Ahead of Print:
19 jun 2018
Resumen:
BACKGROUND: The associations of different patterns of alcohol consumption and the incidence and persistence of depressive and anxiety symptoms in older age remain unclear. METHODS: Data on 6095 adults aged?=?50 years old from the Irish Longitudinal Study on Aging (TILDA) was analyzed. Participants completed the CAGE instrument to screen for problematic alcohol use at baseline between October 2009 and February 2011. Outcomes were incident (assessed by the CES-D scale) and anxiety (assessed by the Hospital Anxiety and Depressive scale) symptoms after a two-year follow-up as well as persistence of probable depression and anxiety among those with a positive screen for those disorders at baseline. Associations were adjusted for potential confounders through multivariable models. RESULTS: In the overall sample, problem drinking did not predict incident and persistent depression and anxiety in this sample. Among females, problem drinking increased the risk for incident depression (OR?=?2.11; 95%CI?=?1.12-4.00) and anxiety (OR?=?2.22; 95%CI?=?1.01-4.86). In addition, problem drinking increased the risk of persistent depressive symptoms (OR?=?2.43; 95%CI?=?1.05-5.06) among females. CONCLUSION: Problem drinking may increase the risk of incident probable depression and anxiety among older females. Furthermore, problem drinking led to a higher likelihood of persistent depressive symptoms in older female participants. Interventions targeting problem drinking among older females may prevent the onset and persistence of depression in this population, while also decreasing the incidence of anxiety symptoms.
Filiaciones:
Carvalho AF:
Department of Psychiatry, University of Toronto, Toronto, ON, Canada
Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada
Stubbs B:
Physiotherapy Department, South London and Maudsley NHS Foundation Trust, London, United Kingdom
Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom
Faculty of Health, Social Care and Education, Anglia Ruskin University, Chelmsford, United Kingdom
Maes M:
Department of Psychiatry, Chulalongkorn University, Bangkok, Thailand
Solmi M:
Department of Neurosciences, University of Padova, Padova, Italy
Vancampfort D:
Department of Rehabilitation Sciences, KU Leuven, Leuven, Belgium
University Psychiatric Center, KU Leuven, Leuven, Kortenberg, Belgium
Kurdyak PA:
Department of Psychiatry, University of Toronto, Toronto, ON, Canada
Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada
Institute for Clinical Evaluative Sciences (ICES), Toronto, ON, Canada
Brunoni AR:
Center for Clinical and Epidemiological Research Interdisciplinary Center for Applied Neuromodulation, University Hospital, University of São Paulo, São Paulo, Brazil
Laboratory of Neuroscience and National Institute of Biomarkers in Psychiatry, Department and Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil
Husain MI:
Department of Psychiatry, University of Toronto, Toronto, ON, Canada
Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada
Koyanagi A:
Research and Development Unit, Parc Sanitari Sant Joan de Déu, Universitat de Barcelona, Fundació Sant Joan de Déu, Dr. Antoni Pujadas, 42, Sant Boi de Llobregat, Barcelona 08830, Spain
Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Monforte de Lemos 3-5 Pabellón 11, Madrid 28029, Spain
Green Submitted, Green Accepted
|